Mohamed Touati

Limoges, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Launching the Association of Hematology Department Heads: Sharing experiences and supporting one another for better leadership

Launching the Association of Hematology Department Heads: Sharing experiences and supporting one another for better leadership

Journal: Bulletin du cancer
Published: March 13, 2026

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Journal: HemaSphere
Published: November 26, 2025

THERANOVA-LIM: Improving access to information on oral treatments for patients and pharmacists

THERANOVA-LIM: Improving access to information on oral treatments for patients and pharmacists

Journal: Bulletin du cancer
Published: August 22, 2025

Feasibility of carfilzomib infusions in hospital at home for patients with multiple myeloma (the Carfil-HAD study)

Feasibility of carfilzomib infusions in hospital at home for patients with multiple myeloma (the Carfil-HAD study)

Journal: Bulletin du cancer
Published: April 25, 2025

Postoperative stage 0 Hodgkin lymphoma. Is surgery alone a curative option?

Postoperative stage 0 Hodgkin lymphoma. Is surgery alone a curative option?

Journal: HemaSphere
Published: October 09, 2024

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.

Journal: European journal of cancer (Oxford, England : 1990)
Published: July 25, 2024

Nurturing and growing a community of department heads: Act 2 in haematology

Nurturing and growing a community of department heads: Act 2 in haematology

Journal: Bulletin du cancer
Published: May 03, 2024

Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.

Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.

Journal: Haematologica
Published: September 20, 2023

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.

Journal: Blood
Published: June 20, 2023

Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.

Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.

Journal: Haematologica
Published: November 08, 2022

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 22, 2022

Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011).

Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 22, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026